Genelux (GNLX) Profit After Tax (2022 - 2026)
Genelux's (GNLX) quarterly Profit After Tax came in at -$8.9 million in Q1 2026, down 18.8% year-on-year from -$11.0 million in Q1 2025, and up 3.87% quarter-over-quarter from -$9.3 million in Q4 2025.
Genelux (GNLX) Profit After Tax (2022 - 2026) Analysis & Trends
Genelux's Profit After Tax history runs 5 years deep, the most recent figure standing at -$8.9 million for Q1 2026.
- On a quarterly basis, Profit After Tax fell 18.8% year-over-year to -$8.9 million in Q1 2026; TTM through Mar 2026 was -$33.6 million, a 14.61% decrease from a year earlier, with the FY2025 full-year figure at -$32.2 million, down 7.98% from the prior year.
- Profit After Tax grew to -$8.9 million in Q1 2026 per GNLX's latest filing, from -$9.3 million in the prior quarter.
- Across five years, Profit After Tax topped out at $4.9 million in Q3 2022 and bottomed at -$10.4 million in Q1 2023.
- The 5-year median for Profit After Tax is -$7.5 million (2025), against an average of -$6.5 million.
- Across the five-year window, Profit After Tax plunged 208.88% in 2023 and climbed 24.26% in 2024, its largest moves.
- Year by year, Profit After Tax stood at -$3.5 million in 2022, then sank by 93.62% to -$6.8 million in 2023, then plunged by 31.9% to -$8.9 million in 2024, then declined by 4.21% to -$9.3 million in 2025, then gained by 3.87% to -$8.9 million in 2026.
- Per Business Quant, the three latest GNLX Profit After Tax figures stand at -$8.9 million (Q1 2026), -$9.3 million (Q4 2025), and -$8.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -453.82 Mn |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - | -8.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.94 Mn |
| Dec 31, 2025 | -9.30 Mn |
| Sep 30, 2025 | -7.95 Mn |
| Jun 30, 2025 | -7.46 Mn |
| Mar 31, 2025 | -7.53 Mn |
| Dec 31, 2024 | -8.93 Mn |
| Sep 30, 2024 | -6.33 Mn |
| Jun 30, 2024 | -6.58 Mn |
| Mar 31, 2024 | -7.85 Mn |
| Dec 31, 2023 | -6.77 Mn |
| Sep 30, 2023 | -5.35 Mn |
| Jun 30, 2023 | -5.82 Mn |
| Mar 31, 2023 | -10.36 Mn |
| Dec 31, 2022 | -3.50 Mn |
| Sep 30, 2022 | 4.91 Mn |